VBI-009
VBI-009 is a CD47 and B7-H3 (CD276) bispecific antibody. VBI-009 blocks CD47-SIRPα 'don't eat me' signals and restricts activity to CD47+/B7-H3+ cells. VBI-009 induces antibody-dependent cellular phagocytosis (ADCP) and antibody-dependent cellular cytotoxicity (ADCC) in CD47+/B7-H3+ tumor cells. VBI-009 inhibits tumor growth in CD47+/B7-H3+ lung cancer xenograft models. VBI-009 can be used for the research of lung cancer.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Human
VBI-009 selectively binds to CD47+/B7-H3+ tumor cells, shows minimal to no binding to B7-H3-negative cells, and does not bind significantly to human red blood cells[1].
VBI-009 potently blocks the CD47/SIRPα axis on CD47+/B7-H3+ tumor cells, with minimal to no activity on B7-H3-negative cells[1].
VBI-009 drives potent antibody-dependent cellular phagocytosis of CD47+/B7-H3+ tumor cells, with minimal to no activity on B7-H3-negative cells[1].
VBI-009 drives potent antibody-dependent cellular cytotoxicity of CD47+/B7-H3+ tumor cells, with minimal to no activity on B7-H3-negative cells[1].
VBI-009 does not induce hemagglutination of human red blood cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Q5ZPR3 & Q61735-1
B7-H3/CD276 & CD47
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Product Image
ELISA, FACS, Functional assay
Chemical Information
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)